The UK drugmaker AstraZeneca has agreed to acquire Belgian cell therapy developer EsoBiotec for up to $1bn to enhance its cancer treatment capabilities. Read more.

CJ ENM CEO Yoon Sang-hyun has talked his $818M content spend, Severance, Netflix and partnerships with Warner Bros.

AstraZeneca will acquire all outstanding equity of EsoBiotec for a total consideration of up to $1,000m, on a cash and debt free basis. This will include an initial payment of $425m on deal closing, ...

When Red Bull Racing Team folded its NASCAR operation in 2011, few imagined the energy drink giant would return to stock car ...

Vector-borne diseases continue to pose significant global health challenges due to their widespread transmission by vectors such as mosquitoes, ticks, ...

John Roehrig died March 8 after a battle with ALS. During his career, he was on the front lines of the U.S. response to West Nile virus.

Valid accounts are being leveraged as an initial attack vector in 2024, representing 31.4% of cases. This, according to an ...

Over the past few months, we’ve been exploring how generative AI can transform trial preparation by analyzing complex litigation materials ...

Hantavirus’s role in the recent tragic death of the actor Gene Hackman and his wife provides an opportunity to educate the ...

EQS-News: GeoVax, Inc. / Key word (s): Financial GeoVax Establishing Strategic Presence in Europe With Initial Footprint in the UK 12.03.2025 / 14:06 CET/CEST The issuer is solely responsible for ...

BrandAlley, a UK-based designer and luxury fashion online retailer, has over eight million members, adds thousands of new ...

MSI’s RTX 50 Series laptops are now available for pre-order in India, with prices starting at ₹2,29,990. Sales begin in April ...